Myriad Genetics MYGN EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
Based on trailing twelve months.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's EBITDA margin?
- Myriad Genetics (MYGN) reported EBITDA margin of -40.7% in Q1 2026.
- How has Myriad Genetics's EBITDA margin changed year-over-year?
- Myriad Genetics's EBITDA margin decreased by 423.3% year-over-year, from -7.8% to -40.7%.
- What is the long-term trend for Myriad Genetics's EBITDA margin?
- Over 5 years (2020 to 2025), Myriad Genetics's EBITDA margin has grown at a 8.8% compound annual growth rate (CAGR), from -26.6% to -40.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.